|The NIH Office of Extramural Research on March 25 released results from two surveys of extramural researchers seeking information on the impacts of COVID-19 to the research enterprise. Initial survey results show respondents indicated concerns about career trajectories and the ability to apply for grants; mental health impacts including from external stressors, isolation, and caregiving duties; and decreased productivity in part due to decreased access to labs and facilities. “The effects of the COVID-19 pandemic have been far-reaching. Our survey findings show that the scientific workforce has not been immune to its effects. It is clear the NIH-funded community of extramural researchers has experienced inequities in several domains, with early-career researchers and those with caregiving responsibilities most affected,” Marie Bernard, MD, acting chief officer for scientific workforce diversity, and Michael Lauer, deputy director for extramural research, said in their summary of the survey results.|
NIH launched an effort to end structural racism in biomedical research through a new initiative called UNITE which is instituting new ways to support diversity, equity, and inclusion, and identifying and dismantling any policies and practices that may harm our workforce and our science. As a key stakeholder invested in biomedical research and/or racial equity, your input to NIH’s efforts will be critical. NIH has released a Request for Information seeking input on practical and effective approaches to improve and strengthen racial equity, diversity, and inclusion across all facets of the biomedical research enterprise, both within NIH and the external community, and expand research to eliminate or lessen health disparities and inequities. Comments can be submitted through the submission website and must be received by April 9, 2021.
NIH Alzheimer’s Research Summits are key strategic planning meetings tied to the implementation of the first goal of the National Plan to Address Alzheimer’s Disease: to effectively treat and prevent Alzheimer’s disease by 2025. They bring together a multi-stakeholder community including government, industry, academia, private foundation, and patient advocacy groups, to further integrated, translational Alzheimer’s research. The goal is to accelerate the development of effective, disease-modifying, and palliative therapies for the cognitive as well as neuropsychiatric symptoms of Alzheimer’s disease.
The 2021 Summit will be held virtually April 19 – April 22 from 10:00 a.m. – 3:30 p.m. ET.
NIH Videocast, April 19-22, 2021, 10 a.m. – 3:30 p.m. ET. Registration is free and open to the public.
The National Institute on Aging will be hosting a virtual meeting to discuss the potential and planning of a practice-based research network (PBRN) to address the disparities gap with the recruitment and retention of diverse and underserved populations to AD/ADRD clinical research studies.
PBRNs are networks of health care clinicians and practices working together to answer community-based health care questions and translate research findings into practice–they have the potential to directly engage diverse and underserved communities in AD/ADRD clinical research.
When: Friday, April 30, 2021; 2:00 – 5:00 p.m. EDT
Keynote Speakers: Lori Minasian, MD, Deputy Director for the National Cancer Institute (NCI) Division of Cancer Prevention and Jonathan N. Tobin, PhD, Cardiovascular Epidemiologist and Professor in the Department of Epidemiology and Population Health at Albert Einstein College of Medicine
Panel Speakers: Jennifer Manly, PhD, Andrea Gilmore-Bykovskyi, PhD, RN, and Jonathan Jackson, PhD
Who Should Attend: Researchers and other stakeholders who are interested in learning about PBRNs to address AD/ADRD research gaps
Click here to register.
Alzheimers.gov is a new educational resource and portal to federal information on Alzheimer’s disease and related dementias for people living with dementia, caregivers, health care providers, community and public health professionals, and researchers. In this webinar, NIA will share the process behind developing Alzheimers.gov and provide a tour of the new website. NIA anticipates that this website will be a valuable resource for our community of stakeholders. No need to register- join here on March 16th.